Hsa-miR-3651 could serve as a novel predictor for in-breast recurrence via FRMD3.
Zellinger B, Bodenhofer U, Engländer IA, Kronberger C, Grambozov B, Ruznic E, Stana M, Karner J, Fastner G, Sotlar K, Sedlmayer F, Zehentmayr F.
Zellinger B, et al. Among authors: karner j.
Breast Cancer. 2022 Mar;29(2):274-286. doi: 10.1007/s12282-021-01308-y. Epub 2021 Dec 5.
Breast Cancer. 2022.
PMID: 34865205
Free PMC article.